Hot Investor Mandate 2: Crossborder Firm Focuses New Fund On Healthcare IT Deals

19 May

A firm with offices in the USA and Middle East has raised a new $50 million fund in 2016. The firm invests $500K to $2 million in late seed stage to Series A rounds, with reserves for follow on investment. The firm primarily invests in private Healthcare IT companies. Their target ownership level is 10-20%. The firm has a flexible capital structure, and is open to investing in the form of convertible notes, debts, or equity, and will consider investments across the globe.

The firm’s primary focus is on Healthcare IT companies; companies with an integrated medical device technology component will also be considered. However the firm prefers a strong focus on the software aspect, and looks for companies in which software is the proprietary technology. Historically the firm has invested in integrated devices such as diagnostics, sequencing, healthcare analytics, and tele-medicine. The firm is highly interested in investing in technologies that are beneficial to healthcare, to improve patient experiences, and reduce healthcare costs.

The firm looks to invest in companies with established and experienced teams. The firm prefers to work with companies that are experts in their respective area. The firm looks to take a board seat, and play an active role in its portfolio companies.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: